Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole-genome analysis suggesting probiotic potential and safety properties of Pediococcus pentosaceus DSPZPP1, a promising LAB strain isolated from traditional fermented sausages of the Basilicata region (Southern Italy).
Tathode MS, Bonomo MG, Zappavigna S, Mang SM, Bocchetti M, Camele I, Caraglia M, Salzano G. Tathode MS, et al. Among authors: zappavigna s. Front Microbiol. 2024 Apr 4;15:1268216. doi: 10.3389/fmicb.2024.1268216. eCollection 2024. Front Microbiol. 2024. PMID: 38638895 Free PMC article.
[Positive selection of hematopoietic CD 34 stem cells for autograft].
Lopez M, Boccaccio C, Douay L, Bony V, Laporte JP, Lesage S, Isnard F, Bouchet S, Giarratanna MC, Zappavigna S, et al. Lopez M, et al. Among authors: zappavigna s. Presse Med. 1993 Oct 16;22(31):1439-43. Presse Med. 1993. PMID: 7505437 French.
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.
Salzano G, Marra M, Porru M, Zappavigna S, Abbruzzese A, La Rotonda MI, Leonetti C, Caraglia M, De Rosa G. Salzano G, et al. Among authors: zappavigna s. Int J Pharm. 2011 Jan 17;403(1-2):292-7. doi: 10.1016/j.ijpharm.2010.10.046. Epub 2010 Nov 3. Int J Pharm. 2011. PMID: 21055454
Emerging pathways as individualized therapeutic target of multiple myeloma.
Misso G, Zappavigna S, Castellano M, De Rosa G, Di Martino MT, Tagliaferri P, Tassone P, Caraglia M. Misso G, et al. Among authors: zappavigna s. Expert Opin Biol Ther. 2013 Jun;13 Suppl 1:S95-109. doi: 10.1517/14712598.2013.807338. Epub 2013 Jun 6. Expert Opin Biol Ther. 2013. PMID: 23738692 Review.
Erlotinib: early clinical development in brain cancer.
Addeo R, Zappavigna S, Parlato C, Caraglia M. Addeo R, et al. Among authors: zappavigna s. Expert Opin Investig Drugs. 2014 Jul;23(7):1027-37. doi: 10.1517/13543784.2014.918950. Epub 2014 May 16. Expert Opin Investig Drugs. 2014. PMID: 24836441 Review.
Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection.
Berretta M, Caraglia M, Martellotta F, Zappavigna S, Lombardi A, Fierro C, Atripaldi L, Muto T, Valente D, De Paoli P, Tirelli U, Di Francia R. Berretta M, et al. Among authors: zappavigna s. Front Pharmacol. 2016 Mar 30;7:71. doi: 10.3389/fphar.2016.00071. eCollection 2016. Front Pharmacol. 2016. PMID: 27065862 Free PMC article. Review.
94 results